Plasma endothelin-1 levels in septic patients. 2007

Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
Department of Anaesthesiology and Intensive Care Unit, Medical University of Lodz, Poland.

Dysfunction of the vascular endothelium (ET) causes an increase in serum ET-1 concentration, as observed in septic patients. It was assumed that in this patient population the ET-1 level correlates with the degree of sepsis severity, including the level of organ dysfunction and, in particular, the level of circulatory dysfunction. The aim of the present study was to assess the relationship between levels of ET-1 and levels of N-terminal brain natriuretic propeptide (NT-proBNP), procalcitonin (PCT), and C-reactive protein (CRP), as well as the Sepsis-related Organ Failure Assessment (SOFA) score in septic patients. PCT and CRP were used to estimate the level of sepsis severity; the SOFA score was used to estimate multiorgan dysfunction; and NT-proBNP was used as a marker of cardiac dysfunction. Twenty patients with sepsis and severe sepsis were included in the study. Blood serum ET-1, NT-proBNP, PCT, and CRP concentrations were determined at specific time intervals, and the SOFA score was calculated. Mean ET-1, NT-proBNP, PCT, and CRP concentrations were 8.39 pg/ml +/- 6.39 pg/mL, 140.80 pg/mL +/- 84.65 pg/mL, 22.32 ng/mL +/- 97.41 ng/mL, and 128.51 mg/L +/- 79.05 mg/L, respectively. Correlation between ET-1 levels and levels of NT-proBNP, PCT, and CRP was .3879 (P < .001), .358 (P < .001), and .225 (P = .011), respectively. Mean SOFA score was 6.31 pts +/- 3.75 pts. Correlation between the ET-1 levels and SOFA score was .470 (P < .001). Six patients (30%) died during the observation period of 28 days. ET-1 levels correlate with levels of NT-proBNP, PCT, and CRP, as well as the SOFA score in septic patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011498 Protein Precursors Precursors, Protein
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
January 1992, Nephron,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
August 1992, Critical care medicine,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
July 1994, British journal of rheumatology,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
March 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
November 1990, The New England journal of medicine,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
April 1994, Clinica chimica acta; international journal of clinical chemistry,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
January 2000, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
December 1996, Cardiovascular surgery (London, England),
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
October 1995, Metabolism: clinical and experimental,
Mariusz Piechota, and Maciej Banach, and Robert Irzmanski, and Marcin Barylski, and Magdalena Piechota-Urbanska, and Jan Kowalski, and Lucjan Pawlicki
May 1991, The New England journal of medicine,
Copied contents to your clipboard!